tadalafil has been researched along with losartan potassium in 2 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (losartan potassium) | Trials (losartan potassium) | Recent Studies (post-2010) (losartan potassium) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 24,390 | 2,493 | 5,408 |
Protein | Taxonomy | tadalafil (IC50) | losartan potassium (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8.53 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0049 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0082 | |
Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Akıncı, AT; Arslantaş, A; Arslantaş, D; Delen, E; Kökoğlu, B; Kökoğlu, Ç; Özbek, Z; Uslu, S | 1 |
2 other study(ies) available for tadalafil and losartan potassium
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Therapeutic efficacy of tadalafil and eriythropoietin in experimental spinal cord injury.
Topics: Administration, Oral; Animals; Disease Models, Animal; Drug Therapy, Combination; Erythropoietin; Infusions, Parenteral; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Tadalafil; Thoracic Vertebrae | 2016 |